The hallmarks of aging: how the field maps biological decline
The short version: aging is not one thing. It is twelve interconnected biological processes the field has agreed to call “hallmarks.” Mapping the system is the first step to understanding it.
TL;DR
- The hallmarks of aging are twelve biological processes that drive cellular and systemic decline.
- The framework was first published in 2013 and updated in 2023 to include three additional hallmarks.
- It is the closest thing the longevity science field has to a shared map.
What the hallmarks are
The hallmarks of aging (in plain English: the dozen biological processes scientists agree are major drivers of how the body ages) are a research framework, not a checklist. The original 2013 paper described nine hallmarks: genomic instability, telomere attrition (shortening of protective DNA caps at the ends of chromosomes), epigenetic alterations, loss of proteostasis (the cell’s ability to fold proteins correctly), deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence (cells that stop dividing but refuse to die), stem-cell exhaustion, and altered intercellular communication (López-Otín et al., Cell, 2013).
How the framework works
Think of the hallmarks as twelve threads in a single rope. Pull on any one thread, and the rope changes shape. The 2023 update added three more: disabled macroautophagy (the cell’s recycling system), chronic inflammation, and dysbiosis (an imbalance in the gut microbiome) (López-Otín et al., Cell, 2023). The hallmarks are interconnected — fixing one often nudges another. That is why no single intervention “treats aging” cleanly.
Who asks about it
People come to this framework after reading longevity books or following researchers like David Sinclair, Eric Verdin, or Peter Attia. The hallmarks are the closest thing the field has to a shared map. About 7 in 10 longevity-focused practitioners reference them directly when explaining how lifestyle and medical interventions are supposed to work.
What the research says
The 2013 paper has been cited tens of thousands of times and shaped how research grants are written, how trials are designed, and how clinicians describe aging to patients. The 2023 update reflects a decade of new evidence — including research on senolytics (drugs that clear senescent cells), microbiome interventions, and autophagy-activating compounds. The framework remains descriptive: it explains what is happening, not what to do about it.
What to know before considering it
The hallmarks are a research tool, not a clinical prescription. Treatments targeting individual hallmarks (rapamycin, metformin, NAD+ precursors, senolytics) are areas of active research. Some are FDA-approved for other indications and used off-label. Compounded longevity medications are not FDA-approved.
The Halftime POV
The hallmarks of aging give the longevity conversation a vocabulary. Without that vocabulary, every claim about “anti-aging” sounds the same. With it, claims can be tested against the framework: which hallmark, which mechanism, which evidence?
Related reading:
- Healthspan vs lifespan: what the longevity field actually studies
- Sarcopenia: the muscle loss most people miss
- NAD+ and peptides: how they work in complementary lanes
FAQ
Q: What are the hallmarks of aging? A: The hallmarks of aging are 12 interconnected biological processes that the longevity research field uses to map cellular and systemic decline. The most recent 2023 update added compromised autophagy, chronic inflammation, and dysbiosis to the original nine.
Q: Who came up with the hallmarks of aging? A: The original framework was published in 2013 in the journal Cell by López-Otín, Blasco, Partridge, Serrano, and Kroemer. The 2023 update was published by the same lead authors and expanded the list from nine to twelve hallmarks.
Q: Are the hallmarks treatable? A: Some hallmarks have research-backed lifestyle interventions (exercise, sleep, diet patterns). Others are areas of active drug and peptide research. None has a single proven treatment that reverses aging — the framework is descriptive, not prescriptive.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
